A major review details how AI enhances early detection and recurrence prediction in breast cancer imaging.
Key Details
- 1Systematic review covers research from 2006–2025 on AI in breast cancer imaging.
- 2AI-assisted mammography detects 29% more cancers compared to conventional reading without increasing false positives.
- 3AI reduces mammography reading time by ~40%, increasing radiologist efficiency.
- 4AI in 3D digital breast tomosynthesis finds 1.6 more cancers per 1,000 screens and reduces recall rate by 2.2%.
- 5AI in MRI identified imaging features up to one year pre-diagnosis and localized future cancer in 57% of cases.
- 6AI models also improve ultrasound interpretation consistency and biopsy analysis for recurrence risk.
Why It Matters
The review synthesizes evidence showing that AI not only boosts diagnostic accuracy and efficiency across imaging modalities, but also supports risk prediction and precision medicine. This highlights the growing value of AI as a clinical decision-support tool in breast imaging and underscores the challenges ahead for broad, equitable clinical adoption.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.